KTX-0141 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,837 results for “KTX-0141”

Trials

View all 1520 →

Active, not recruiting

IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study

150 participants · First posted Jun 14, 2022

Not yet recruiting

An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients

55 participants · First posted Dec 18, 2024

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

144 participants · First posted Aug 5, 2025

Drugs

View all 1177 →

DasKloster 0141-01

ALX-0141

Organizations

GTX INC

United States

GTx, Inc.

United States

NTX Catalyst Health Network, Inc.

United States

News

View all 134 →

Kasvu Therapeutics Raises €30M to Advance Non-Hallucinogenic TrkB-Targeting Depression Drug KTX-0141

K36 Therapeutics Receives FDA Clearance for First-in-Class Multiple Myeloma Drug KTX-1001

Bristol-Myers Squibb Advances Two Multiple Myeloma Trials with Novel Drug Combinations

Page 1 of 284